Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia

Journal of Nuclear Medicine

Volumn 47, Issue 4, 2006, Pages 574-580

  Beeres, Saskia L M A ^a   Bax, Jeroen J ^a   Dibbets, Petra ^a   Stokkel, Marcel P M ^a   Zeppenfeld, Katja ^a   Fibbe, Willem E ^a   Van Der Wall, Ernst E ^a   Schalij, Martin J ^a   Atsma, Douwe E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F FDG SPECT; 99mTc tetrofosmin SPECT; Bone marrow cells; Ischemic heart disease; Myocardial perfusion

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; ILIAC CREST; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERFUSION; PRIORITY JOURNAL; REVASCULARIZATION; SCAR; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; DRUG RESISTANCE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INJECTION; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING; TRANSPLANTATION;

AGED; ANGINA PECTORIS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; DRUG RESISTANCE; FLUORODEOXYGLUCOSE F18; HUMANS; INJECTIONS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR FUNCTION, LEFT;

EID: 33745111628     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47-49.
2. Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. J Am Coll Cardiol. 2003;41:1721-1724.
3. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-2302.
4. Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110 (suppl II):II-213-II-218.
5. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function. Nat Med. 2001;7:430-436.
6. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature. 2001;410:701-705.
7. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands and cytokines. Circulation. 2001;104:1046-1052.
8. Kawamoto A, Tkebuchava T, Yamagucki J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461-468.
9. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100 (suppl II):II-247-II-256.
10. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93-98.
11. Liu Y, Guo J, Zhang P, et al. Bone marrow mononuclear cell transplantation into heart elevates the expression of angiogenic factors. Microvasc Res. 2004;68:156-160.
12. Silva GV, Litovsky S, Assad JAR, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005;111:150-156.
13. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 2000;101:1465-1478.
14. Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31:261-291.
15. Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med. 2000;30:281-298.
16. 18F-Deoxyglucose and the assessment of myocardial viability. Semin Nucl Med. 2002;32:60-69.
17. Germano G, Berman DS. Quantitative gated SPECT. J Nucl Med. 2001;42:528-529.
18. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
19. Sharir T, Berman DS, Waechter PB, et al. Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med. 2001;42:1630-1638.
20. Berman DS, Abidov A, Kang X, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol. 2004;11:414-423.
21. 18FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med. 2003;44:877-883.
22. Nuutila P, Knuuti MJ, Raitakari M, et al. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol. 1994;267:E941-E946.
23. Bax JJ, Veening MA, Visser FC, et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: a comparative study using different protocols. Eur J Nucl Med. 1997;24:35-41.